M. Koshibu

Antiatherogenic effects of liraglutide in hyperglycemic apolipoprotein E-null mice via AMP-activated protein kinase-independent mechanisms.

T. Hirano, Hideki Kushima, Munenori Hiromura, 2019, American journal of physiology. Endocrinology and metabolism.

Involvement of Vascular Endothelial Cells in the Anti-atherogenic Effects of Liraglutide in Diabetic Apolipoprotein E-null Mice

T. Hirano, Tomoki Fujikawa, Naoya Osaka, 2019, The Showa University Journal of Medical Sciences.

Two cases with Hb Andrew-Minneapolis showing high or low-normal HbA1c levels depending on the measurement method.

M. Koga, S. Kasayama, S. Sumitani, 2019, Clinica chimica acta; international journal of clinical chemistry.

A Dipeptidyl Peptidase-4 Inhibitor Suppresses Macrophage Foam Cell Formation in Diabetic db/db Mice and Type 2 Diabetes Patients

T. Hirano, Hideki Kushima, Munenori Hiromura, 2018, International journal of endocrinology.

Nesfatin-1 suppresses peripheral arterial remodeling without elevating blood pressure in mice

T. Hirano, H. Ohtaki, Hideki Kushima, 2019, Endocrine connections.

Luseogliflozin attenuates neointimal hyperplasia after wire injury in high-fat diet-fed mice via inhibition of perivascular adipose tissue remodeling

S. Yamagishi, H. Ohtaki, M. Ohara, 2019, Cardiovascular diabetology.

Association of glucose and blood pressure variability on oxidative stress in patients with type 2 diabetes mellitus and hypertension: a cross-sectional study

T. Hirano, Toshiyuki Hayashi, H. Nagaike, 2019, Diabetology & Metabolic Syndrome.

Glucose-Dependent Insulinotropic Polypeptide Suppresses Peripheral Arterial Remodeling in Male Mice.

Yuichiro Yamada, Y. Seino, T. Hirano, 2018, Endocrinology.

The role of endothelial nitric oxide in the anti-restenotic effects of liraglutide in a mouse model of restenosis

T. Hirano, Hideki Kushima, Munenori Hiromura, 2017, Cardiovascular Diabetology.